𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Addiction to protein kinase CK2: A common denominator of diverse cancer cells?

✍ Scribed by Maria Ruzzene; Lorenzo A. Pinna


Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
344 KB
Volume
1804
Category
Article
ISSN
1570-9639

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Cell cycle dependent regulation of prote
✍ Huamin Wang; Shihui Yu; Alan T. Davis; Khalil Ahmed πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 194 KB πŸ‘ 1 views

## Abstract Protein kinase CK2 is a ubiquitous protein serine/threonine kinase that is involved in cell growth and proliferation as well as suppression of apoptosis. Several studies have suggested that the kinase plays a role in cell cycle progression; however, changes in enzyme activity during pha

Protein kinase CK2 promotes cancer cell
✍ Roger Yefi; Daniela P. Ponce; Ignacio Niechi; Eduardo Silva; Pablo Cabello; Dieg πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 608 KB

## Abstract Augmented expression of protein kinase CK2 is associated with hyperproliferation and resistance to apoptosis in cancer cells. Effects of CK2 are at least partially linked to signaling via the Wnt/β‐catenin pathway, which is dramatically enhanced in colon cancer. Cyclooxygenase‐2 (COX‐2)

A peptide fragment of ependymin neurotro
✍ David S. Adams; Brendan Hasson; Anne Boyer-Boiteau; Adam El-Khishin; Victor E. S πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 376 KB πŸ‘ 1 views

## Abstract Ependymin (EPN) is a goldfish brain neurotrophic factor previously shown to function in a variety of cellular events related to long‐term memory formation and neuronal regeneration. CMX‐8933, an 8‐amino‐acid synthetic peptide fragment of EPN, was designed for aiding an investigation of

Lapatinib, a dual HER1/HER2 tyrosine kin
✍ Alejandro Vazquez-Martin; Cristina Oliveras-Ferraros; Silvia CufΓ­; Sonia Del Bar πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 252 KB

## Abstract The ultimate biological and clinical meaning of shed HER2 extracellular domain (ECD) has remained largely unclear until recently. Oversecretion of soluble HER2 ECD has been shown to inhibit growth of HER2‐overexpressing cancer cells by promoting HER2 ECD dimerization with HER transmembr